Select the Industry/ Sector šŸ‘‰    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,316.9
₹63,572 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹26,545.4
₹56,407 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,398.0
₹30,195 Cr
Pharmaceuticals & Drugs
₹969.7
₹19,060 Cr
Pharmaceuticals & Drugs
₹606.4
₹5,496 Cr
Pharmaceuticals & Drugs
₹485.9
₹4,467 Cr
Pharmaceuticals & Drugs
₹381.4
₹4,265 Cr
Pharmaceuticals & Drugs
₹99.0
₹2,542 Cr
Pharmaceuticals & Drugs
₹1,172.8
₹669 Cr
Pharmaceuticals & Drugs
₹51.5
₹145 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,316.9
₹12,634 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹969.7
₹6,229 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,398.0
₹4,209 Cr
Pharmaceuticals & Drugs
₹485.9
₹2,529 Cr
Pharmaceuticals & Drugs
₹606.4
₹1,853 Cr
Pharmaceuticals & Drugs
₹381.4
₹624 Cr
Pharmaceuticals & Drugs
₹99.0
₹157 Cr
Pharmaceuticals & Drugs
₹26,545.4
₹5,849 Cr
Pharmaceuticals & Drugs
₹1,172.8
₹362 Cr
Pharmaceuticals & Drugs
₹51.5
₹343 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,316.9
₹1,575 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,398.0
₹816 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹969.7
₹617 Cr
Pharmaceuticals & Drugs
₹606.4
₹217 Cr
Pharmaceuticals & Drugs
₹485.9
₹172 Cr
Pharmaceuticals & Drugs
₹381.4
₹137 Cr
Pharmaceuticals & Drugs
₹99.0
₹93 Cr
Pharmaceuticals & Drugs
₹26,545.4
₹1,201 Cr
Pharmaceuticals & Drugs
₹1,172.8
₹75 Cr
Pharmaceuticals & Drugs
₹51.5
₹4 Cr

You may also like the below Video Courses